Lotazin Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
IQUR Co., Ltd.
MFDS item code 201907311 · Approved 2019.10.17
This product's status changed to Expired on 2024.10.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension not controlled with monotherapy
This medicine is used for patients with hypertension whose blood pressure is not adequately controlled with monotherapy. It effectively lowers blood pressure and reduces the risk of cardiovascular diseases.
○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. In general, the maximum blood pressure-lowering effect is seen approximately 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, initiate treatment with this medicine when monotherapy has not produced the desired effect. 1. Substitution therapy: The combination of individually dose-adjusted losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Initiate treatment with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Initiate treatment with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be initiated with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which allows the hydrochlorothiazide dose to be reduced without reducing the overall blood pressure-lowering effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment Administer the usual dose to patients with a creatinine clearance of 30 mL/min or more. Use of this medicine is not recommended in patients with more severe renal impairment, as loop diuretics are preferable to thiazide-type drugs in these patients. ○ Patients with hepatic impairment Use of this medicine is not recommended in patients with hepatic impairment requiring dose adjustment, because the initial dose of losartan potassium of 25 mg for these patients cannot be administered using this medicine.
Children (under 18 years): As there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medicine can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters; therefore, discontinuation is necessary immediately upon confirmation of pregnancy. Patients with allergies to this medicine or its components, severely impaired kidney function, severely damaged liver function, those who are pregnant or may become pregnant should not use this medicine. Patients with low blood pressure, abnormal kidney function, liver disease, gout, or electrolyte imbalance should exercise particular caution when using this medicine, as blood pressure could drop too low or kidney function could worsen; therefore, follow the doctor's instructions. During treatment with this medicine, regular checks of potassium levels in the blood and electrolyte status are necessary to ensure there are no abnormalities, and potassium supplements or potassium-containing salt substitutes should not be taken without consulting a doctor. Due to the hydrochlorothiazide component, skin may become sensitive to sunlight, so it is advised to avoid sun exposure and to inform a doctor immediately of any unusual skin changes. Caution is needed while driving or operating machinery, as dizziness or drowsiness may occur, especially during the initial stages of treatment or with dosage changes. There may be interactions with other medications; therefore, it is essential to inform your doctor or pharmacist about any current medications, especially when taken with potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs, and lithium. The safety and efficacy of this medicine have not been confirmed in children or adolescents, so it should not be used in these populations. Elderly patients may experience side effects more frequently, necessitating regular observation and testing. In the event of overdose, hypotension or arrhythmias may occur, so it is essential to contact a medical institution immediately, as the components of this medicine are not removed by hemodialysis and special treatments may be required. This medicine should be stored out of reach of children and kept sealed in its original container.
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to light, so it should be stored in a tightly sealed container that blocks light. It is recommended to maintain a storage temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness and safety of the medicine for a longer period.
Yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
IQUR Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.